<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ateroskleroz</journal-id><journal-title-group><journal-title xml:lang="ru">Атеросклероз</journal-title><trans-title-group xml:lang="en"><trans-title>Ateroscleroz</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-256X</issn><issn pub-type="epub">2949-3633</issn><publisher><publisher-name>НИИТПМ-филиал ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52727/2078-256X-2025-21-3-296-308</article-id><article-id custom-type="elpub" pub-id-type="custom">ateroskleroz-1132</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Кардиометаболические факторы риска и остеопоротические переломы у лиц старше 50 лет (Новосибирск)</article-title><trans-title-group xml:lang="en"><trans-title>Cardiometabolic risk factors and osteoporotic fractures in people aged over 50 years (Novosibirsk)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3351-1993</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мазуренко</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Mazurenko</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Сергеевна Мазуренко, канд. мед. наук, научный сотрудник</p><p>630089, г. Новосибирск, ул. Бориса Богаткова, 175/1</p></bio><bio xml:lang="en"><p>Elena S. Mazurenko, candidate of medical sciences, researcher</p><p>175/1, Boris Bogatkov st., Novosibirsk, 630089</p></bio><email xlink:type="simple">poltorackayaes@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4095-0169</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рымар</surname><given-names>О. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Rymar</surname><given-names>O. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Оксана Дмитриевна Рымар, д-р мед. наук, главный научный сотрудник с в.о., зав. лабораторией клинико-популяционных и профилактических исследований терапевтических и эндокринных заболеваний</p><p>630089, г. Новосибирск, ул. Бориса Богаткова, 175/1</p></bio><bio xml:lang="en"><p>Oksana D. Rymar, doctor of medical sciences, chief researcher, head of the laboratory of clinical-population and preventive research of therapeutic and endocrine</p><p>175/1, Boris Bogatkov st., Novosibirsk, 630089</p></bio><email xlink:type="simple">orymar23@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9270-9188</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щербакова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shcherbakova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лилия Валерьевна Щербакова, старший научный сотрудник</p><p>630089, г. Новосибирск, ул. Бориса Богаткова, 175/1</p></bio><bio xml:lang="en"><p>Liliya V. Shcherbakova, senior researcher</p><p>175/1, Boris Bogatkov st., Novosibirsk, 630089</p></bio><email xlink:type="simple">9584792@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3801-6844</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Диреев</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Direev</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Артем Олегович Диреев, канд. мед. наук, младший научный сотрудник</p><p>630089, г. Новосибирск, ул. Бориса Богаткова, 175/1</p></bio><bio xml:lang="en"><p>Artem O. Direev, candidate of medical sciences, junior researcher</p><p>175/1, Boris Bogatkov st., Novosibirsk, 630089</p></bio><email xlink:type="simple">dr.direev@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чурсина</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Chursina</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вероника Николаевна Чурсина, врач-ординатор</p><p>630089, г. Новосибирск, ул. Бориса Богаткова, 175/1</p></bio><bio xml:lang="en"><p>Veronika N. Chursina, resident</p><p>175/1, Boris Bogatkov st., Novosibirsk, 630089</p></bio><email xlink:type="simple">veronica.golotina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6539-0466</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малютина</surname><given-names>С. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Malyutina</surname><given-names>S. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Софья Константиновна Малютина, д-р мед. наук, проф., главный научный сотрудник с в.о., зав. лабораторией этиопатогенеза и клиники терапевтических заболеваний</p><p>630089, г. Новосибирск, ул. Бориса Богаткова, 175/1</p></bio><bio xml:lang="en"><p>Sofia K. Malyutina, doctor of medical sciences, professor, head of the laboratory of etiopathogenesis and clinics of internal diseases</p><p>175/1, Boris Bogatkov st., Novosibirsk, 630089</p></bio><email xlink:type="simple">smalyutina@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт терапии и профилактической медицины – филиал Федерального государственного бюджетного научного учреждения «Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения Российской академии наук»</institution></aff><aff xml:lang="en"><institution>Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>29</day><month>09</month><year>2025</year></pub-date><volume>21</volume><issue>3</issue><fpage>296</fpage><lpage>308</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мазуренко Е.С., Рымар О.Д., Щербакова Л.В., Диреев А.О., Чурсина В.Н., Малютина С.К., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Мазуренко Е.С., Рымар О.Д., Щербакова Л.В., Диреев А.О., Чурсина В.Н., Малютина С.К.</copyright-holder><copyright-holder xml:lang="en">Mazurenko E.S., Rymar O.D., Shcherbakova L.V., Direev A.O., Chursina V.N., Malyutina S.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ateroskleroz.elpub.ru/jour/article/view/1132">https://ateroskleroz.elpub.ru/jour/article/view/1132</self-uri><abstract><p>Цель — изучить ассоциации кардиометаболических факторов риска (КФР) и остеопоротических переломов (ОП) у лиц старше 50 лет (Новосибирск).Материал и методы. Проведен анализ данных, полученных в российской части международного проекта HAPIEЕ (Новосибирск, 2003—2005 гг.). В настоящий анализ включено 7363 мужчин и женщин 50—69 лет. Проведены сбор информации о частоте ОП за последние 12 месяцев при помощи структурированного опросника, оценка социально-демографических параметров и КФР (ожирение, гипергликемия, дислипидемии, продолжительность менопаузы у женщин, привычка табакокурения, потребление алкоголя), прием заместительной гормональной терапии у женщин в постменопаузе. Выполнен анализ ассоциаций КФР с шансом ОП.Результаты. Частота ОП за последние 12 месяцев составила 3,6 % (3,2 % у мужчин и 4,0 % у женщин, р = 0,074). Шанс ОП у мужчин увеличивался при повышении артериального давления (АД), холестерина липопротеинов высокой плотности (ХС ЛПВП) в крови, потреблении этанола более 30 г за один прием и уменьшался при увеличении индекса массы тала (ИМТ). У женщин шанс перелома увеличивался при курении в настоящее время, увеличении длительности постменопаузы, уменьшался с увеличением уровня триглицеридов (ТГ) независимо от других факторов.Заключение. Среди обследованных лиц старше 50 лет выявлена синдемия КФР в отношении связи с ОП: у мужчин шанс ОП возрастал при увеличении уровней АД и ХС ЛПВП в крови, потреблении этанола более 30 г за один прием и уменьшался при увеличении ИМТ; у женщин шанс перелома увеличивался при курении в настоящее время, увеличении длительности постменопаузы и уменьшался с увеличением уровня ТГ независимо от других фаторов. Полученные данные позволяют говорить о существенных связях ХНИЗ с ОП.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To study the associations between cardiometabolic risk factors (CRF) and osteoporotic fractures (OF) in a population sample aged over 50 years.Materials and methods. The cross-sectional study was based on Russian part of the HAPIEE Project (Novosibirsk, 2003–2005). This analysis included 7363 men and women 50–69 years old. We collected information on the OF over the past 12 months using a standard questionnaire, we assessed socio-demographic parameters and the main CRF (obesity, hyperglycemia, dyslipidemia, menopause duration in women, smoking, alcohol consumption), and taking of hormone replacement therapy in postmenopausal women. The analysis of associations between CRF and the chance of OF was performed.Results. The frequency of OF over the past 12 months was 3.6 % (3.2 % in men and 4.0 % in women, p = 0.074). The risk of fracture was directly associated with blood pressure, HDL cholesterol, and ethanol consumption of more than 30 g per 1 session, and it was inversely associated with BMI among men. In women, the chance of a fracture was directly associated with current smoking, an increase in the menopause duration and inversely associated with TG level independent of other factors.Conclusion. Among the examined persons over 50 years of age, we reveled the syndemia of CRF in relation to OF risk in men, the chance of OF has positive association with an increase of blood pressure and HDL-C levels, ethanol consumption of more than 30 g per session and negative association with BMI value; in women, the chance of fracture positively associated with current smoking, postmenopausal duration, and negatively associated with TG level, regardless of other factors. The data obtained make it possible to speak of significant links between CRF and OF.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>остеопороз</kwd><kwd>остеопоротический перелом</kwd><kwd>липидный обмен</kwd><kwd>кардиометаболические факторы риска</kwd></kwd-group><kwd-group xml:lang="en"><kwd>osteoporosis</kwd><kwd>osteoporotic fractures</kwd><kwd>lipid metabolism</kwd><kwd>cardiometabolic risk factors</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Анализ кардиометаболических факторов поддержан грантом РНФ № 24-015-00433. Исследование остепоретических переломов поддержано бюджетной темой НИ-ИТПМ — филиал ИЦиГ СО РАН ГЗ № FWNR 2024-0002.</funding-statement><funding-statement xml:lang="en">Analysis of cardiometabolic factors is supported by RSF grant 24-15-00433. The study of osteoporotic fractures was carried out within the budget project FWNR 2024-0002.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Лесняк О.М. Аудит состояния проблемы остеопороза в странах Восточной Европы и Центральной Азии 2010. Остеопороз и остеопатии, 2011; 14 (2): 3–6. doi: 10.14341/osteo201123-6</mixed-citation><mixed-citation xml:lang="en">Lesnyak O.M. Audit of the state of the problem of osteoporosis in the countries of Eastern Europe and Central Asia 2010. Osteoporosis and Osteopathy, 2011; 14 (2): 3–6. (In Russ.). doi: 10.14341/osteo201123-6</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Khosla S., Hofbauer L.C. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol., 2017; 5 (11): 898–907. doi: 10.1016/S2213-8587(17)30188-2</mixed-citation><mixed-citation xml:lang="en">Khosla S., Hofbauer L.C. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol., 2017; 5 (11): 898–907. doi: 10.1016/S2213-8587(17)30188-2</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Mazurenko E.S., Malyutina S.K., Shcherbakova L.V., Mustafina S.V., Nikitenko Т.М., Bobak M., Rymar O.D. The forearm fractures in patients with diabetes and without diabetes in population sample aged over 50 years (Novosibirsk). Problems of Endocrinology, 2019; 65 (2): 79–88. doi: 10.14341/probl9799</mixed-citation><mixed-citation xml:lang="en">Mazurenko E.S., Malyutina S.K., Shcherbakova L.V., Mustafina S.V., Nikitenko Т.М., Bobak M., Rymar O.D. The forearm fractures in patients with diabetes and without diabetes in population sample aged over 50 years (Novosibirsk). Problems of Endocrinology, 2019; 65 (2): 79–88. doi: 10.14341/probl9799</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mazurenko E., Rymar O., Rerikh V., Khrapova Y., Direev A., Shcherbakova L., Malyutina S. Risk factors for chronic non-communicable diseases and osteoporotic fractures in a middle and elderly-aged population. J. Pers. Med., 2022; 12: 1475. doi: 10.3390/jpm12091475</mixed-citation><mixed-citation xml:lang="en">Mazurenko E., Rymar O., Rerikh V., Khrapova Y., Direev A., Shcherbakova L., Malyutina S. Risk factors for chronic non-communicable diseases and osteoporotic fractures in a middle and elderly-aged population. J. Pers. Med., 2022; 12: 1475. doi: 10.3390/jpm12091475</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Li C., Zeng, Y., Tao L., Liu S., Ni Z., Huang Q., Wang Q. Meta-analysis of hypertension and osteoporotic fracture risk in women and men. Osteoporos Int., 2017; 28: 2309–2318. doi: 10.1007/s00198-017-4050-z</mixed-citation><mixed-citation xml:lang="en">Li C., Zeng, Y., Tao L., Liu S., Ni Z., Huang Q., Wang Q. Meta-analysis of hypertension and osteoporotic fracture risk in women and men. Osteoporos Int., 2017; 28: 2309–2318. doi: 10.1007/s00198-017-4050-z</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Renjithlal S., Magdi M., Mostafa M., Renjith K., Pillai P., Syed M., Mohamed S., Zahid V., Ritter N., Al Ali O., Balmer-Swain M., Makaryus A., Pillai N. Bone mineral density as a predictor of cardiovascular disease in women: a real-world retrospective study. J. Endocrinol. Metab., 2022; 12 (4-5): 125–133 doi: 10.14740/jem840</mixed-citation><mixed-citation xml:lang="en">Renjithlal S., Magdi M., Mostafa M., Renjith K., Pillai P., Syed M., Mohamed S., Zahid V., Ritter N., Al Ali O., Balmer-Swain M., Makaryus A., Pillai N. Bone mineral density as a predictor of cardiovascular disease in women: a real-world retrospective study. J. Endocrinol. Metab., 2022; 12 (4-5): 125–133 doi: 10.14740/jem840</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Li G., Cheung C., Au P., Tan K., Wong I., Sham P. Positive effects of low LDL-C and statins on bone mineral density: an integrated epidemiological observation analysis and Mendelian randomization study. Int. J. Epidemiol., 2020; 49 (4): 1221–1235. doi: 10.1093/ije/dyz145</mixed-citation><mixed-citation xml:lang="en">Li G., Cheung C., Au P., Tan K., Wong I., Sham P. Positive effects of low LDL-C and statins on bone mineral density: an integrated epidemiological observation analysis and Mendelian randomization study. Int. J. Epidemiol., 2020; 49 (4): 1221–1235. doi: 10.1093/ije/dyz145</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao J., Liang G., Luof M., Yang W., Xua N., Luo M., Pan J., Liu J., Zeng L. Influence of type 2 diabetes microangiopathy on bone mineral density and bone metabolism: A meta-analysis. Heliyon, 2022; 8 (10): e11001. doi: 10.1016/j.heliyon.2022.e11001</mixed-citation><mixed-citation xml:lang="en">Zhao J., Liang G., Luof M., Yang W., Xua N., Luo M., Pan J., Liu J., Zeng L. Influence of type 2 diabetes microangiopathy on bone mineral density and bone metabolism: A meta-analysis. Heliyon, 2022; 8 (10): e11001. doi: 10.1016/j.heliyon.2022.e11001</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Мазуренко Е.С., Малютина С.К., Щербакова Л.В., Храпова Ю.В., Исаева М.П., Рымар О.Д. Риск переломов по шкале FRAX в течение 10 лет у пожилых пациентов с сахарным диабетом 2-го типа. Терапевт. арх., 2019; 91 (10): 76–81. doi: 10. 26442/00403660.2019.10.000113</mixed-citation><mixed-citation xml:lang="en">Mazurenko E.S., Malyutina S.K., Shcherbakova L.V., Khrapova Yu.V., Isaeva М.P., Rymar O.D. 10-year risk of fractures (FRAX) in people with diabetes type 2 in the elderly. Therapeutic Archive, 2019; 91 (10): 76–81. (In Russ.). doi: 10.26442/00403660.2019.10.000113</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Мунц И.В., Диреев А.О., Веревкин Е.Г., Мезенцев Е.М., Шапкина М.Ю., Авдеева Е.М., Мазуренко Е.С., Bobak M., Малютина С.К., Рябиков А.Н. Вопросы коморбидности сердечно-сосудистых и хронических неинфекционных заболеваний с офтальмологическими заболеваниями в популяции. Клин. медицина, 2019; 97 (1): 18–25. doi: 10.34651/0023-2149-2019-97-1-18-25</mixed-citation><mixed-citation xml:lang="en">Munz I.V., Direev A.O., Verevkin E.G., Mezentsev E.M., Shapkina M.Yu., Avdeeva E.M., Mazurenko E.S., Bobak M., Malyutina S.K., Ryabikov A.N. The comorbidity of cardiovascular and non-communicable diseases with ophthalmologic diseases in population. Klin. Med., 2019; 97 (1): 18–25 (In Russ.). doi: 10.34651/0023-2149-2019-97-1-18-25</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Peasey A., Bobak M., Kubinova R., Malyutina S., Pajak A., Tamosiunas A., Pikhart H., Nicholson A., Marmot M. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health, 2006; 6: 255. doi: 10.1186/1471-2458-6-255</mixed-citation><mixed-citation xml:lang="en">Peasey A., Bobak M., Kubinova R., Malyutina S., Pajak A., Tamosiunas A., Pikhart H., Nicholson A., Marmot M. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health, 2006; 6: 255. doi: 10.1186/1471-2458-6-255</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Tevik K., Bergh S., Selbæk G., Johannessen A., Helvik A.S. A systematic review of self-report measures used in epidemiological studies to assess alcohol consumption among older adults. PLoS One, 2021; 16 (12): e0261292. doi: 10.1371/journal.pone.0261292</mixed-citation><mixed-citation xml:lang="en">Tevik K., Bergh S., Selbæk G., Johannessen A., Helvik A.S. A systematic review of self-report measures used in epidemiological studies to assess alcohol consumption among older adults. PLoS One, 2021; 16 (12): e0261292. doi: 10.1371/journal.pone.0261292</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Department of Noncommunicable Disease Management. Screening for Type 2 Diabetes Report of a World Health Organization and International Diabetes Federation meeting. Geneva, 2003.</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Department of Noncommunicable Disease Management. Screening for Type 2 Diabetes Report of a World Health Organization and International Diabetes Federation meeting. Geneva, 2003.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hiligsmann M., Kanis J.A., Compston J., Cooper С., Flamion B., Bergmann P., Body J.J., Boonen S., Bruyere O., Devogelaer J.P., Goemaere S., Kaufman J.M., Rozenberg S., Reginster J.Y. Health technology assessment in osteoporosis. Calcif. Tissue Int., 2013; 93 (1): 1–14. doi: 10.1007/s00223-013-9724-8</mixed-citation><mixed-citation xml:lang="en">Hiligsmann M., Kanis J.A., Compston J., Cooper С., Flamion B., Bergmann P., Body J.J., Boonen S., Bruyere O., Devogelaer J.P., Goemaere S., Kaufman J.M., Rozenberg S., Reginster J.Y. Health technology assessment in osteoporosis. Calcif. Tissue Int., 2013; 93 (1): 1–14. doi: 10.1007/s00223-013-9724-8</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Гладкова Е.Н., Ходырев В.Н., Лесняк О.М. Эпидемиологическое исследование остеопоротических переломов у жителей Среднего Урала старших возрастных групп. Науч.-практ. ревматология, 2014; 52 (6): 643–649. doi: 10.14412/1995-4484-2014-643-649</mixed-citation><mixed-citation xml:lang="en">Gladkova E.N., Khodyrev V.N., Lesnyak O.M. An episrmiological survey of osteoporotic fractures in older residents from the Middle Urals. Rheumatol. Sci. Pract., 2014; 52 (6): 643–649. (In Russ.). doi: 10.14412/1995-4484-2014-643-649</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ghorabi S., Shab-Bidar S., Sadeghi O., Nasiri M., Khatibi S.R., Djafarian K. Lipid profile and risk of bone fracture: a systematic review and meta-analysis of observational studies. Endocr. Res., 2019; 44 (4): 168–184. doi: 10.1080/07435800.2019.1625057</mixed-citation><mixed-citation xml:lang="en">Ghorabi S., Shab-Bidar S., Sadeghi O., Nasiri M., Khatibi S.R., Djafarian K. Lipid profile and risk of bone fracture: a systematic review and meta-analysis of observational studies. Endocr. Res., 2019; 44 (4): 168–184. doi: 10.1080/07435800.2019.1625057</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y.Y., Wang W.W., Yang L., Chen W.W., Zhang H.X. Association between lipid profiles and osteoporosis in postmenopausal women: a meta-analysis. Eur. Rev. Med. Pharmacol. Sci., 2018; 22 (1): 1–9. doi: 10.26355/eurrev_201801_14093</mixed-citation><mixed-citation xml:lang="en">Chen Y.Y., Wang W.W., Yang L., Chen W.W., Zhang H.X. Association between lipid profiles and osteoporosis in postmenopausal women: a meta-analysis. Eur. Rev. Med. Pharmacol. Sci., 2018; 22 (1): 1–9. doi: 10.26355/eurrev_201801_14093</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X., Zhang L., Wang X., Cao H., Liu Sh., Wang Y. Impact of cardiovascular risk factors on osteoporosis among different age patients with coronary artery disease. J. Res. Cardiol., 2016 (2016): Article ID 307728. doi: 10.5171/2016.30772</mixed-citation><mixed-citation xml:lang="en">Chen X., Zhang L., Wang X., Cao H., Liu Sh., Wang Y. Impact of cardiovascular risk factors on osteoporosis among different age patients with coronary artery disease. J. Res. Cardiol., 2016 (2016): Article ID 307728. doi: 10.5171/2016.30772</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hussain S.M., Ebeling P.R., Barker A.L., Beilin L.J., Tonkin A.M., McNeil J.J. Association of plasma high-density lipoprotein cholesterol level with risk of fractures in healthy older adults. JAMA Cardiol., 2023; 8 (3): 268–272. doi: 10.1001/jamacardio.2022.5124</mixed-citation><mixed-citation xml:lang="en">Hussain S.M., Ebeling P.R., Barker A.L., Beilin L.J., Tonkin A.M., McNeil J.J. Association of plasma high-density lipoprotein cholesterol level with risk of fractures in healthy older adults. JAMA Cardiol., 2023; 8 (3): 268–272. doi: 10.1001/jamacardio.2022.5124</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmed L.A., Schirmer H., Berntsen G.K., Fønnebø V., Joakimsen R.M. Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromsø study. Osteoporos Int., 2006; 17 (3): 426–432. doi: 10.1007/s00198-005-0003-z</mixed-citation><mixed-citation xml:lang="en">Ahmed L.A., Schirmer H., Berntsen G.K., Fønnebø V., Joakimsen R.M. Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromsø study. Osteoporos Int., 2006; 17 (3): 426–432. doi: 10.1007/s00198-005-0003-z</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kha H.T., Basseri B., Shouhed D., Richardson J., Tetradis S., Hahn T.J., Parhami F. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. J Bone Miner. Res., 2004; 19: 830–840. doi: 10.1359/JBMR.040115</mixed-citation><mixed-citation xml:lang="en">Kha H.T., Basseri B., Shouhed D., Richardson J., Tetradis S., Hahn T.J., Parhami F. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. J Bone Miner. Res., 2004; 19: 830–840. doi: 10.1359/JBMR.040115</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Parhami F., Morrow A.D., Balucan J., Leitinger N., Watson A.D., Tintut Y., Berliner J.A., Demer L.L. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol., 1997; 17 (4): 680–687. doi: 10.1161/01.atv.17.4.680</mixed-citation><mixed-citation xml:lang="en">Parhami F., Morrow A.D., Balucan J., Leitinger N., Watson A.D., Tintut Y., Berliner J.A., Demer L.L. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol., 1997; 17 (4): 680–687. doi: 10.1161/01.atv.17.4.680</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Papachristou N.I., Blair H.C., Kypreos K.E., Papachristou D.J. High-density lipoprotein (HDL) metabolism and bone mass. J. Endocrinol., 2017; 233 (2): R95–R107. doi: 10.1530/JOE-16-0657</mixed-citation><mixed-citation xml:lang="en">Papachristou N.I., Blair H.C., Kypreos K.E., Papachristou D.J. High-density lipoprotein (HDL) metabolism and bone mass. J. Endocrinol., 2017; 233 (2): R95–R107. doi: 10.1530/JOE-16-0657</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Chen G.C., Qin L.Q., Ye J.K. Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis. Obes. Rev., 2014; 15 (2): 134–142. doi: 10.1111/obr.12088</mixed-citation><mixed-citation xml:lang="en">Chen G.C., Qin L.Q., Ye J.K. Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis. Obes. Rev., 2014; 15 (2): 134–142. doi: 10.1111/obr.12088</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Schrieks I.C., Heil A.L., Hendriks H.F., Mukamal K.J., Beulens J.W. The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies. Diabetes Care, 2015; 38 (4): 723–732. doi: 10.2337/dc14-1556</mixed-citation><mixed-citation xml:lang="en">Schrieks I.C., Heil A.L., Hendriks H.F., Mukamal K.J., Beulens J.W. The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies. Diabetes Care, 2015; 38 (4): 723–732. doi: 10.2337/dc14-1556</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Sözen T., Özışık L., Başaran N.Ç. An overview and management of osteoporosis. Eur. J. Rheumatol., 2017; 4 (1): 46–56. doi: 10.5152/eurjrheum.2016.048</mixed-citation><mixed-citation xml:lang="en">Sözen T., Özışık L., Başaran N.Ç. An overview and management of osteoporosis. Eur. J. Rheumatol., 2017; 4 (1): 46–56. doi: 10.5152/eurjrheum.2016.048</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Y., Ye J. Association between hypertension and osteoporosis: a population-based cross-sectional study. BMC Musculoskelet Disord., 2024; 25 (1): 434. doi: 10.1186/s12891-024-07553-4</mixed-citation><mixed-citation xml:lang="en">Huang Y., Ye J. Association between hypertension and osteoporosis: a population-based cross-sectional study. BMC Musculoskelet Disord., 2024; 25 (1): 434. doi: 10.1186/s12891-024-07553-4</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Jin H., Zhao H., Jin S., Yi X., Liu X., Wang C., Zhang G., Pan J. Menopause modified the association of blood pressure with osteoporosis among gender: a large-scale cross-sectional study. Front. Public Health, 2024; 12: 1383349. doi: 10.3389/fpubh.2024.1383349</mixed-citation><mixed-citation xml:lang="en">Jin H., Zhao H., Jin S., Yi X., Liu X., Wang C., Zhang G., Pan J. Menopause modified the association of blood pressure with osteoporosis among gender: a large-scale cross-sectional study. Front. Public Health, 2024; 12: 1383349. doi: 10.3389/fpubh.2024.1383349</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Turcotte A.F., O’Connor S., Morin S.N., Gibbs J.C., Willie B.M., Jean S., Gagnon C. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: A systematic review and meta-analysis. PLoS One, 2021; 16 (6): e0252487. doi: 10.1371/journal.pone.0252487</mixed-citation><mixed-citation xml:lang="en">Turcotte A.F., O’Connor S., Morin S.N., Gibbs J.C., Willie B.M., Jean S., Gagnon C. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: A systematic review and meta-analysis. PLoS One, 2021; 16 (6): e0252487. doi: 10.1371/journal.pone.0252487</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Armutcu F., McCloskey E. fracture risk assessment in metabolic syndrome in terms of secondary osteoporosis potential. A narrative review. Calcif. Tissue Int., 2025: 20; 116 (1): 41. doi: 10.1007/s00223-025-01341-5</mixed-citation><mixed-citation xml:lang="en">Armutcu F., McCloskey E. fracture risk assessment in metabolic syndrome in terms of secondary osteoporosis potential. A narrative review. Calcif. Tissue Int., 2025: 20; 116 (1): 41. doi: 10.1007/s00223-025-01341-5</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Мазуренко Е.С. Факторы риска падений как предикторы остеопоротических переломов у лиц с сахарным диабетом. Медицинский совет, 2019; 4: 104–107. doi: 10.21518/2079-701X-2019-4-104-107</mixed-citation><mixed-citation xml:lang="en">Mazurenko E.S. Fall risk factors as predictors of osteoporotic fractures in people with diabetes mellitus. Medical Council, 2019; (4): 104–107. (In Russ.). doi: 10.21518/2079-701X-2019-4-104-107</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Мазуренко Е.С., Малютина С.К., Щербакова Л.В., Рагино Ю.И., Рымар О.Д. Факторы риска остеопоротических переломов дистального отдела предплечья у женщин в постменопаузе в популяции Новосибирска. Практич. медицина, 2018; 16 (9): 174–179. doi: 10.32000/2072-1757-2018-9-174-179</mixed-citation><mixed-citation xml:lang="en">Mazurenko E.S., Malyutina S.K., Shcherbakova L.V., Ragino Yu.I., Rymar O.D. Risk factors for osteoporotic fractures of the distal forearm in postmenopausal women in the Novosibirsk population. Pract. Med., 2018; 16 (9): 174–179 (In Russ.). doi: 10.32000/2072-1757-2018-9-174-179</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
